Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-Current Debt (2021 - 2025)

Bioregenx (BRGX) has 5 years of Non-Current Debt data on record, last reported at $181069.0 in Q3 2025.

  • For Q3 2025, Non-Current Debt fell 84.36% year-over-year to $181069.0; the TTM value through Sep 2025 reached $181069.0, down 84.36%, while the annual FY2024 figure was $1.1 million, 116.62% up from the prior year.
  • Non-Current Debt reached $181069.0 in Q3 2025 per BRGX's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.2 million in Q3 2024 and bottomed at $150000.0 in Q1 2024.
  • Average Non-Current Debt over 5 years is $537218.5, with a median of $227528.5 recorded in 2021.
  • Peak YoY movement for Non-Current Debt: skyrocketed 461.98% in 2024, then crashed 84.36% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $197837.0 in 2021, then dropped by 1.02% to $195811.0 in 2022, then skyrocketed by 168.46% to $525681.0 in 2023, then soared by 116.62% to $1.1 million in 2024, then crashed by 84.1% to $181069.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $181069.0 in Q3 2025, $1.2 million in Q2 2025, and $257220.0 in Q1 2025.